Lilly to present phase 3 data on Foundayo, retatrutide at ADA

Markets Investing.com By Investing.com 28 May 2026 17:41 1 min read

Lilly to present phase 3 data on Foundayo, retatrutide at ADA

Lilly to present phase 3 data on Foundayo, retatrutide at ADA

Lilly to present phase 3 data on Foundayo, retatrutide at ADA

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.